BUD vs. TAP, STZ and ABEV: Four Beer Dividends, Four Different Risk Profiles

In 2023, Bud Light's marketing misstep led to a significant market shift, with competitors like Michelob Ultra and Constellation's Modelo Especial capitalizing on its decline. As these brands gained ground, Molson Coors' Coors Light and Miller Lite surged, now outpacing Bud Light by 50%. For high-income professionals, the key takeaway is to focus on dividend sustainability rather than market narratives, as the financial health of these brands varies significantly despite their shared industry challenges.

The Bud Light Redistribution

BUD vs ABEV vs STZ vs TAP — Performance Comparison
BUD vs ABEV vs STZ vs TAP — Performance Comparison

In 2023, a marketing misstep turned the best-selling beer in America into a boycott target. Bud Light lost the #1 US volume crown, and the share it shed didn't disappear — it scattered across the industry.

Michelob Ultra, also an AB InBev brand, eventually clawed the top spot back. Constellation's Modelo Especial held #1 from mid-2023 until Michelob Ultra retook it in September 2025, and caught the premium and Hispanic end. And the quietest name in the group, Molson Coors, picked up the value-lager end: Coors Light and Miller Lite combined are now, per Molson Coors' CEO, roughly 50% bigger than Bud Light, and those gains have largely held.

So four brewers all get lumped together as "beer dividend stocks." But as income holdings, they have almost nothing in common — different currencies, payout structures, and dividend-safety math. The question for an income reader isn't who won the shelf. It's whose dividend the cash flow actually supports.

What the 1-year chart shows

The total-return chart above complicates the tidy narrative. BUD trades at $79.10, up in the day, and sits in the upper half of its $57.79–$86.60 52-week range — the relative-strength name of the group. STZ ($131.43) and TAP ($41.66) both trade within a few percent of their 52-week lows ($126.45 and $38.04). ABEV ($2.88) sits mid-range.

The read: this isn't one washed-out bargain against three winners. The market has rewarded the wounded incumbent's recovery and punished two of the share-catchers. Cheapness and "who won the boycott" are pointing in different directions — which is exactly why the dividend math, not the share-war story, has to carry the analysis. Worth naming directly: the best-performing line on the chart is ABEV, up roughly 38% on the year (BUD second, ~28%) — the name with the weakest coverage and least predictable income led on total return. One more axis pointing a different way.

Performance and yield figures are historical and may change. Total return includes price movement and distributions where available. Past performance does not guarantee future results. Yield is not the same as total return. All figures are as of market close, August 27–28, 2026.

How each one makes money

BUD (Anheuser-Busch InBev) is the global scale player — $59.32B in FY2025 revenue at a 56% gross margin, built on Budweiser, Michelob Ultra, Corona (ex-US), Stella and a vast emerging-market footprint. Its story is deleveraging: the SABMiller acquisition debt that forced two dividend cuts (2018, 2020) is finally worked down, and the payout is rebuilding off a low base.

ABEV (Ambev) is the Brazilian outlier — AB InBev owns roughly 62% of it. It is not fighting the US share war. It reports in reais, runs a net-cash balance sheet, and returns capital largely through "interest on capital" (JCP), a variable, tax-advantaged Brazilian distribution. That structure matters enormously for the ADR check, as we'll see.

STZ (Constellation Brands) is the US-premium beer engine — Modelo and Corona in the States (a different arrangement than BUD's international Corona rights), where beer now drives the business after wine and spirits divestitures. Modelo caught the premium end of the redistribution.

TAP (Molson Coors) is the value/light-lager house — Coors Light, Miller Lite, Molson, Blue Moon. It caught the biggest, most durable slice of the Bud Light defectors, and it has been raising its dividend and buying back stock while doing it.

The dividend: coverage, not headline yield

Here is the core of the piece. The honest dividend-safety test is free-cash-flow coverage — cash generated against cash paid out — not the earnings payout ratio, and especially not GAAP EPS, which impairments distort in two of these names.

Premium

Subscribe to Informed Investing

Subscribe free to read the full article — and unlock the complete archive.

We respect your inbox. Unsubscribe anytime.

We respect your inbox. Unsubscribe anytime.


Disclosure: This article is for informational and educational purposes only and is not financial, investment, tax, or legal advice. References to specific securities, tickers, companies, or strategies are provided for informational purposes only and do not constitute a recommendation, solicitation, or offer to buy or sell any security or financial product. We do not provide individualized advice or act as a fiduciary. Investing involves risk, including loss of principal, and past performance is not indicative of future results. We may hold positions in securities mentioned. You should independently verify information before acting on it and consult a qualified professional as needed.